참고문헌 (27)

1. Cleves MA, Sanchez N, Draheim M. Evaluation of two competing methods for calculating Charlson s comorbidity index when analyzing short-term mortality using administrative data. J Clin Epidemiol 1997; 50(8): 903-908 

   상세보기

2. Kim HY. Relationship between Hospital Volume and Risk-Adjusted Mortality Rate Following Percutaneous Coronary Intervention [dissertation]. Seoul: Korea University; 2007. (Korean) 

3. Lee KS, Lee SI. Does a higher coronary artery bypass graft surgery volume always have a low in-hospital mortality rate in Korea? J Prev Med Public Health 2006; 39(1): 13-20. (Korean) 

4. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40(5): 373-383 

   상세보기

5. Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in medicare populations. Health Serv Res 2003; 38(4): 1103-1120 

   상세보기

6. Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005; 28(5): 759-762 

   상세보기

7. Birim O, Maat AP, Kappetein AP, van Meerbeeck JP, Damhuis RA, Bogers AJ. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg 2003; 23(1): 30-34 

   상세보기

8. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36(1): 8-27 

   상세보기

9. Stukenborg GJ, Wagner DP, Connors AF Jr. Comparison of the performance of two comorbidity measures, with and without information from prior hospitalization. Med Care 2001; 39(7): 727-739 

   상세보기

10. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/ Deyo methods of comorbidity measurement in administrative data. Med Care 2004; 42(4): 355-360 

    상세보기

11. Preen DB, Holman CD, Spilsbury K, Semmens JB, Brameld KJ. Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol 2006; 59(9): 940-946 

    상세보기

12. Lee DS, Donovan L, Austin PC, Gong Y, Liu PP, Rouleau JL, et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 2005; 43(2): 182-188 

    상세보기

13. Agency for Healthcare Research and Quality. AHRQ Quality Indicators-Guide to Inpatient Quality Indicators: Quality of Care in Hospitals-Volume, Mortality, and Utilization. Rockville: Agency for Healthcare Research and Quality; 2002. Report No.: AHRQ Pub. No. 02-RO204 

14. Alidoosti M, Salarifar M, Zeinali AM, Kassaian SE, Dehkordi MR. Comparison of outcomes of percutaneous coronary intervetion on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: A corss-sectional study. BMC Cardiovacs Disord 2007; 7: 7 

    상세보기

15. Burton KR, Slack R, Oldroyd KG, Pell AC, Flapan AD, Starkey IR, et al. Hosptial volume of throughput and periprocedural and mediumterm adverse events after percutaneous coronary intervention: Retrospective cohort study of all 17,417 procedures undertaken in Scotland, 1997-2003. Heart 2006; 92(11): 1667-1672 

    상세보기

16. Carey JS, Danielsen B, Gold JP, Rossiter SJ. Procedure rates and outcomes of coronary revascularization procedures in California and New York. J Thorac Cardiovasc Surg 2005; 129(6): 1276-1282 

    상세보기

17. Epstein AJ, Rathore SS, Krumholz HM, Volpp KG. Volume-based referral for cardiovascular procedures in the United States: A crosssectional regression analysis. BMC Health Serv Res 2005; 5: 42 

    상세보기

18. Harjai KJ, Berman AD, Grines CL, Kahn J, Marsalese D, Mehta RH, et al. Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stenting. Am J Cardiol 2004; 94(4): 421-426 

    상세보기

19. Halfon P, Eggli Y, van Melle G, Chevalier J, Wasserfallen JB, Burnand B. Measuring potentially avoidable hospital readmissions. J Clin Epidemiol 2002; 55(6): 573-587 

    상세보기

20. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004; 57(12): 1288-1294 

    상세보기

21. Sundararajan V, Quan H, Halfon P, Fushimi K, Luthi J, Burnand B, et al. Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care 2007; 45(12): 1210-1215 

    상세보기

22. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43(11): 1130-1139 

    상세보기

23. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53(12): 1258-1267 

    상세보기

24. Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res 2008; 8: 12 

    상세보기

25. Zavascki AP, Fuchs SC. The need for reappraisal of AIDS score weight of Charlson comorbidity index. J Clin Epidemiol 2007; 60(9): 867-868 

    상세보기

26. Zhang JX, Iwashyna TJ, Christakis NA. The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in medicare claims. Med Care 1999; 37(11): 1128-1139 

    상세보기

27. Kim JY, Kim HY, Im JH. Development of Risk Adjustment and Prediction Methods for Care Episodes using National Health Insurance Database. Seoul: Health Insurance Review & Assessment Service; 2007. (Korean) 

저자의 다른 논문 :

김경훈 (11)